Baird Reiterates Outperform on AdaptHealth, Maintains $20 Price Target
Portfolio Pulse from richadhand@benzinga.com
Baird analyst Eric Coldwell has reiterated his 'Outperform' rating on AdaptHealth (NASDAQ:AHCO) and maintained a price target of $20.
June 28, 2023 | 2:04 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Baird analyst Eric Coldwell has reiterated his 'Outperform' rating on AdaptHealth, maintaining a price target of $20.
The reiteration of the 'Outperform' rating and the maintenance of the $20 price target by Baird's analyst Eric Coldwell indicates a positive outlook for AdaptHealth. This could potentially lead to an increase in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100